TD-0025
N/A
Report date: 2023/07/01 20:00:34
NME
Base Information
Drug NameTD-0025
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVietstar Biomedical Research
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesVietstar Biomedical Research
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A